Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jun 2026 for Akebia Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ron Frieson: trading record in brief
This profile gathers the share dealings of Ron Frieson in Akebia Therapeutics, Inc., where the filings describe the role as board member. Over a trading history stretching from 8 June 2022 to 17 June 2026, the count stands at 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 22 June 2026 with a share grant in Akebia Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ron Frieson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
35,700 sharesCommon StockSEC:0001890219-26-000001:0
35,700 shares0Common StockSEC:0001562180-25-004718:0
20,100 shares@ US$0.45100.0% of flowCommon StockSEC:0001562180-25-000453:0
30,000 shares0Common StockSEC:0001562180-24-004905:0
30,000 shares0Common StockSEC:0001562180-23-004958:0
13,700 shares0Common StockSEC:0001562180-22-004974:0
6 of 6 declarations
